Old Web
English
Sign In
Acemap
>
Paper
>
Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia
Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia
2021
Christina Rautenberg
Friedrich Stölzel
Christoph Röllig
Matthias Stelljes
Verena I. Gaidzik
Michael Lauseker
Oliver Kriege
Mareike Verbeek
Julia M. Unglaub
Felicitas Thol
Stefan W. Krause
Mathias Haenel
Charlotte Neuerburg
Vladan Vucinic
Christian Jehn
Julia Severmann
Maxi Wass
Lars Fransecky
Jens M. Chemnitz
Udo Holtick
Kerstin Schäfer-Eckart
Josephine Schrøder
Sabrina Kraus
William Krüger
Ulrich Kaiser
Sebastian Scholl
Lea Henning
Guido Kobbe
Rainer Haas
Nael Alakel
Maximilian Alexander Röhnert
Katja Sockel
Maher Hanoun
Uwe Platzbecker
Tobias A.W. Holderried
Anke Morgner
Michael Heuser
Tim Sauer
Katharina Goetze
Eva Wagner
Konstanze Döhner
Hartmut Döhner
Christoph Schliemann
Johannes Schetelig
Martin Bornhäuser
Ulrich Germing
Thomas Schroeder
Moritz Moritz Middeke
Keywords:
Oncology
Myeloid leukemia
Internal medicine
Medicine
first line treatment
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]